Physician Practice Management: MSO Structure, CPOM, and the PE Model

Introduction

Physician practice management is the single most active PE consolidation vertical in healthcare, generating more deal volume than any other sub-sector. The combination of extreme fragmentation (hundreds of thousands of independent practices across dozens of specialties), attractive margins (15-30% EBITDA depending on specialty), and a structural shift toward physician employment creates the conditions for sustained consolidation activity that has accelerated every year for the past decade. But PPM deals are uniquely complex because of state-level legal restrictions that prohibit corporations from practicing medicine, requiring specialized ownership structures that healthcare bankers must understand to advise on transactions, value targets, and assess regulatory risk.

This article covers the legal doctrine that shapes every PPM transaction, the MSO structure that enables PE investment, the consolidation playbook that creates value, and the specialty-specific dynamics that healthcare bankers use to evaluate PPM deals.

Corporate Practice of Medicine (CPOM)

A legal doctrine, adopted in approximately 33 US states (with varying levels of enforcement), that prohibits corporations from directly employing physicians, exercising control over medical decision-making, or sharing in the fees generated from the practice of medicine. The doctrine is rooted in the principle that medical judgment should be free from commercial influence: a corporate employer motivated by profit might pressure physicians to over-treat (generating more revenue) or under-treat (reducing costs) in ways that harm patient care. In states with strong CPOM laws (California, Texas, New York, Illinois, New Jersey), a PE-backed company cannot simply buy a physician practice and employ the doctors. Instead, it must use a management services organization (MSO) structure that separates clinical operations from business management. The strength, interpretation, and enforcement of CPOM varies significantly by state, creating a complex patchwork of legal requirements that complicates multi-state practice roll-ups and requires state-specific legal counsel for each new market.

CPOM does not prevent PE investment in physician practices; it constrains the structure. The workaround that has enabled billions of dollars of PE investment in physician practices over the past 15 years is the MSO model, which has been refined and validated through thousands of transactions.

CPOM Variation by State

States fall into roughly three categories of CPOM enforcement:

Strong CPOM states (California, Texas, New York, Illinois, New Jersey): These states actively enforce the doctrine through attorney general actions, medical board oversight, and court decisions. Corporate entities cannot employ physicians under any circumstances and must use strict MSO/PC structures with genuine physician control over clinical matters. California's enforcement has been particularly aggressive, with multiple investigations into whether MSO arrangements give corporations impermissible control over medical practices.

Moderate CPOM states (most of the 33 CPOM states): The doctrine exists but enforcement is less active. MSO structures are still required but may face less scrutiny. The legal standards for what constitutes "corporate practice" are sometimes less well-defined, creating ambiguity that requires careful legal navigation.

No CPOM or weak CPOM states (approximately 17 states including many Southern states): In these states, corporate entities can directly employ physicians without MSO structures. PPM transactions in these states are structurally simpler, though companies often still use MSO structures for consistency across multi-state platforms.

The MSO structure is the legal and economic architecture that enables PE investment in physician practices. It separates a physician practice into two entities with distinct roles, ownership, and economic functions.

The Professional Corporation (PC) or Professional Association (PA): Owned by a licensed physician (the "friendly physician"), this entity holds the medical licenses required to practice medicine, employs or contracts with the physicians and clinical staff, maintains clinical decision-making authority over patient care, and is the entity that bills payers and receives reimbursement. The PC is the legal entity that practices medicine and is therefore compliant with CPOM requirements.

The Management Services Organization (MSO): Owned by the PE-backed company, the MSO provides all non-clinical services to the PC: revenue cycle management and billing, IT infrastructure and electronic health records, human resources for non-clinical staff, regulatory compliance, marketing and patient acquisition, real estate management, procurement and supply chain, and general business management. The MSO charges the PC a management fee for these services.

The Friendly Physician

The physician who owns the PC is often called the "friendly physician" because they are aligned with the PE-backed MSO's interests. The friendly physician must be a licensed physician in the state where the PC operates but does not necessarily need to be the primary practicing physician at every location. Their role is to serve as the legal owner of the PC to comply with CPOM requirements, participate in governance decisions affecting clinical operations, and ensure that the PC retains appropriate clinical autonomy.

The friendly physician typically has an equity stake in the MSO (aligning economic interests), a personal services agreement for any clinical work they perform, and veto rights over clinical decisions (ensuring CPOM compliance). The selection and management of friendly physicians is an important deal structuring consideration: the physician must be genuinely engaged in clinical governance (not a figurehead), must be committed to the platform long-term, and must be replaceable if they leave (the MSA typically includes provisions for appointing a successor friendly physician).

Target Specialty Identification

PE firms target physician specialties with characteristics that make consolidation economically attractive and operationally feasible:

The ideal target specialty has five characteristics: (1) high fragmentation (many small independent practices with motivated sellers), (2) strong commercial payer mix (higher reimbursement rates per encounter), (3) significant ancillary revenue opportunities (in-office procedures, imaging, pathology, dispensing that can be added or optimized post-acquisition), (4) favorable physician demographics (aging physician-owners nearing retirement who want to monetize their practices, younger physicians preferring employment), and (5) defensible against reimbursement cuts (specialties with strong commercial payer mix are less exposed to government reimbursement changes).

Value Creation Levers

Once the platform is established, PE-backed PPM companies create value through five primary levers that healthcare bankers should understand and quantify when advising on transactions:

Revenue cycle management (RCM) centralization. Small independent practices typically have 5-15% revenue leakage from coding errors (under-coding services actually performed), claim denials (submitting claims incorrectly or without required documentation), slow collections (failing to follow up on unpaid claims), and patient balance write-offs. Centralizing RCM onto a professional billing platform with trained coders, automated claim scrubbing, denial management workflows, and systematic patient collections recovers much of this leakage, often adding 5-10% to net patient revenue with minimal incremental cost.

Payer contract renegotiation. A 3-physician dermatology practice has minimal negotiating leverage with commercial payers. The practice represents a tiny fraction of the payer's network, and the payer can credibly threaten to terminate the contract knowing patients have other options. A 200-physician dermatology platform covering 15 states can negotiate 10-20% rate increases by offering payers network adequacy (guaranteeing patient access across a broad geography), quality metrics (demonstrating better outcomes or lower total cost of care), and simplified contracting (one agreement covering dozens of locations rather than separate negotiations with each practice).

Ancillary service capture. Many physician specialties generate significant ancillary revenue from in-office procedures, pathology, imaging, and dispensing. A dermatology practice that outsources its pathology to an external lab is foregoing high-margin revenue that could be captured internally. A centralized platform can invest in equipment (path lab setup, imaging machines), regulatory compliance (CLIA certification, state licensing), and workflow optimization to increase ancillary capture rates, adding high-margin revenue (40-60% margins on ancillaries) that flows directly to EBITDA.

De novo expansion. In addition to acquisitions, PPM platforms can open new practice locations in underserved markets. De novo locations avoid acquisition premiums (no goodwill, no seller multiple) and can be designed from the ground up with optimal workflows, modern facilities, and efficient layouts. However, de novos take 12-24 months to reach mature profitability (building a patient panel takes time), require upfront investment ($200,000-500,000 per location for buildout and initial operating losses), and depend on physician recruitment in competitive labor markets.

[Provider productivity](/guides/healthcare-investment-banking/provider-productivity-wrvus-fmv) optimization. Through better scheduling templates (reducing gaps and no-shows), support staffing (adding medical assistants and scribes so physicians spend more time with patients), workflow redesign (streamlining intake, charting, and follow-up), and technology (EHR optimization, telehealth for appropriate visits), platforms can increase provider productivity (measured in wRVUs or visits per day) without increasing provider burnout, driving incremental revenue from the same physician base.

The next article covers ambulatory surgery centers, where the site-of-care shift from hospitals to outpatient settings creates one of the strongest secular growth stories in healthcare services.